Regenerative solutions for dentistry and oral maxillofacial care
BioCellgraft, Inc. is a biotechnology and regenerative medicine company identifying, developing, commercializing, and distributing innovative regenerative solutions—led by our flagship product platform, OraFyl®.
This corporate site may include forward-looking statements about future objectives and potential development areas.
Regenerative first
We start with biology—then translate it into real-world clinical workflows.
Clinically practical
Handling, consistency, storage, shelf-life, and repeatability matter.
Built to scale responsibly
Quality mindset, documentation discipline, and clear communication are non-negotiable.
A platform approach to oral regeneration
The future of regenerative oral health will be defined by solutions that meet real-world clinical needs.
- High-performing in real clinical settings
- Reliable and consistent over time
- Stable and convenient (long shelf-life; minimal storage complexity)
- Flexible in form to match modern workflows
- Designed for clarity with transparent documentation
Our goal is to build what clinicians wish existed—then validate it with discipline.
Where we're focused
ECM-inspired biomaterial platforms
Flowable and deliverable formats designed for procedural workflows
Barrier and membrane concepts aligned with surgical handling needs
Next-generation oral regeneration candidates under evaluation for future development
A note on what "ideal" looks like
In our view, the ideal regenerative oral health product would be exceptionally capable, broadly useful, and operationally simple—high performance without unnecessary complexity; stable yet adaptable; long shelf-life without special handling burdens; and designed to fit seamlessly into modern clinical workflows.
This is our north star: build what clinicians wish existed—then prove it the right way.